Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles

Eur J Pharm Biopharm. 2019 Aug:141:70-80. doi: 10.1016/j.ejpb.2019.05.006. Epub 2019 May 10.

Abstract

Upon intravenous administration of nanoparticles (NP) into the bloodstream, proteins bind rapidly on their surface resulting in a formation of a so-called 'Protein Corona'. These proteins are strongly attached to the NP surface and provide a new biological identity which is crucial for the reaction at the nano-biointerface. The structure and composition of the protein corona is greatly determined by the physico-chemical properties of the NP and the characteristics of the biological environment. The overall objective of this study was to characterize the role of NP size/surface curvature and PEGylation on the formation of the protein corona. Therefore, we prepared NP in a size of 100 and 200 nm using the biodegradable polymers poly(DL-lactide-co-glycolide) (PLGA) and poly(DL-lactide-co-glycolide)-co-polyethylene glycol diblock (PLGA-PEG) and subsequently incubated them with fetal bovine serum (FBS) to induce the formation of a protein corona. After removal of unbound protein, we employed different analytical approaches to study the corona in detail. Sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) was performed to gain a first impression about amount and composition of the corona proteins. Identification was carried out after tryptic in-solution digestion and liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS). In addition, we successfully established the Bradford protein assay as a suitable colorimetric method to quantify total adsorbed protein amount after alkaline hydrolysis of PLGA based NP. Our results revealed that protein adsorption on PLGA- and PLGA-PEG-NP didn't depend on NP size within the range of 100 and 200 nm. PEGylation led to a significant reduced amount of bound proteins. The depletion of proteins which are involved in immune response was remarkable and indicated a prolonged circulation time in body.

Keywords: Nanoparticles; Particle size; Poly(ethylene glycol); Poly(lactide-co-glycolic acid); Protein corona; Proteomics; Stealth coatings; ‘Stealth’ nanoparticles.

MeSH terms

  • Adsorption / drug effects
  • Drug Carriers
  • Drug Delivery Systems / methods
  • Humans
  • Nanoparticles / chemistry*
  • Particle Size
  • Polyesters / chemistry
  • Polyethylene Glycols / chemistry
  • Polyglycolic Acid / chemistry*
  • Polylactic Acid-Polyglycolic Acid Copolymer / chemistry*
  • Protein Corona / chemistry*
  • Surface Properties / drug effects

Substances

  • Drug Carriers
  • Polyesters
  • Protein Corona
  • polyethylene glycol-poly(lactide-co-glycolide)
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Polyethylene Glycols